LINC00926 and breast cancer: Zhong chu [61] demonstrated that LINC00926 interacts with PGK1 and promotes its ubiquitination and degradation by binding to the E3 ligase STUB1, which is the first E3 ligase responsible for PGK1 degradation and may be a potential therapeutic target for breast cancer.